NEW YORK, May 26, 2021 /PRNewswire/ -- Bruderman Brothers, LLC ("Bruderman Brothers"), is pleased to announce the successful sale of HealthEx Corporation ("HealthEx") to Associated Courier, Inc. ("ACI ...
Principal is secured and repaid through maturities of the SLS portfolio. Interest (7.5% p.a.) is paid from project revenues. Coverage ratios are maintained at a minimum of 125% of note value. Funds ...
The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31, 2023.
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of SELLAS Life Sciences Group (NASDAQ:SLS) with a Overweight recommendation. As of August 31, 2023, the average one-year ...
SELLAS Life Sciences Group Inc. Times Square Tower 7 Times Square Suite 2503 New York, New York 10026 Phone1 646 200-5278 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2024 ...
What is the current share price of SELLAS Life Sciences Group (SLS)? SELLAS Life Sciences Group's (SLS) current share price is $4.57. This constitutes a price movement of 10.12% when compared to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results